CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
H. Lundbeck A/S Company Snapshot
H. Lundbeck A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other pharmaceutical manufacturers in Europe: Hikma Pharmaceuticals PLC of the United Kingdom (2016 sales of £1.45 billion [US$1.81 billion] ), Ipsen SA of France (1.67 billion Euro [US$1.80 billion] ), and Stada Arzneimittel AG which is based in Germany (2.15 billion Euro [US$2.32 billion] ).

Sales Analysis. H. Lundbeck A/S reported sales of 15.63 billion Danish Kroner (US$2.27 billion) for the year ending December of 2016. This represents an increase of 7.1% versus 2015, when the company's sales were 14.59 billion Danish Kroner. The sales level in 2016 was fairly close to the level five years ago: in 2011, H. Lundbeck A/S had sales of 16.01 billion Danish Kroner. Sales of Brintellix/trintellix saw an increase that was more than double the company's growth rate: sales were up 75.7% in 2016, from 629.00 million Danish Kroner to 1.11 billion Danish Kroner. H. Lundbeck A/S also saw significant increases in sales in Onfi (up 37.1% to 2.41 billion Danish Kroner) and Sabril (up 36.2% to 1.34 billion Danish Kroner) and Abilify Maintena (up 66.5% to 1.11 billion Danish Kroner) . Not all segments of H. Lundbeck A/S experienced an increase in sales in 2016: sales of Xenazine fell 28.6% to 1.57 billion Danish Kroner. H. Lundbeck A/S also experienced decreases in sales in Other Pharmaceuticals (down 6.3% to 2.99 billion Danish Kroner) and Cipralex (down 2.8% to 2.52 billion Danish Kroner) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
H. Lundbeck A/S
  Stock Performance Chart for H. Lundbeck A/S
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 318.40
(Figures in Danish Kroner)
1 Week 3.6%   13 Weeks 8.7%  
4 Weeks 14.7%   52 Weeks 28.4%  
 
H. Lundbeck A/S Key Data:
  Ticker: LUN Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 15,634,000,000
(Year Ending Jan 2017).
Employees: 4,983
  Currency: Danish Kroner Market Cap: 62,835,773,226
  Fiscal Yr Ends: December Shares Outstanding: 197,348,534
  Share Type: Stammaktie Closely Held Shares: 137,351,918
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.